{"organizations": [], "uuid": "01219f2472959f421a85f1558d2c88c7eedaea68", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/7", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/30/globe-newswire-maxim-group-llc-expands-equity-research-platform-with-the-appointment-of-a-senior-biotechnology-analyst.html", "country": "US", "domain_rank": 767, "title": "Maxim Group LLC Expands Equity Research Platform With the Appointment of a Senior Biotechnology Analyst", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-30T16:00:00.000+03:00", "replies_count": 0, "uuid": "01219f2472959f421a85f1558d2c88c7eedaea68"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/30/globe-newswire-maxim-group-llc-expands-equity-research-platform-with-the-appointment-of-a-senior-biotechnology-analyst.html", "ord_in_thread": 0, "title": "Maxim Group LLC Expands Equity Research Platform With the Appointment of a Senior Biotechnology Analyst", "locations": [], "entities": {"persons": [{"name": "anthony v. vendetti", "sentiment": "none"}, {"name": "caroline palomeque", "sentiment": "none"}, {"name": "palomeque", "sentiment": "none"}, {"name": "natexis bleichroeder", "sentiment": "none"}, {"name": "caroline", "sentiment": "none"}], "locations": [], "organizations": [{"name": "maxim group llc expands equity research platform", "sentiment": "negative"}, {"name": "maxim group llc", "sentiment": "negative"}, {"name": "wallachbeth capital", "sentiment": "none"}, {"name": "jmp securities", "sentiment": "none"}, {"name": "oppenheimer", "sentiment": "none"}, {"name": "maxim group", "sentiment": "none"}, {"name": "head of equity research", "sentiment": "none"}, {"name": "equity research", "sentiment": "none"}, {"name": "goldman sachs", "sentiment": "none"}, {"name": "noble life science partners", "sentiment": "none"}, {"name": "mount sinai school of medicine", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- Maxim Group LLC, a leading full service investment banking, securities and wealth management firm today announced the expansion of its Equity Research platform with the appointment of Caroline Palomeque as a Senior Vice President and Senior Biotechnology Analyst.\nPrior to joining Maxim Group, Ms. Palomeque was a Senior Research Analyst covering the Biotechnology sector at Noble Life Science Partners and WallachBeth Capital. She has equity research experience at Oppenheimer, JMP Securities, Goldman Sachs, and Natexis Bleichroeder. Ms. Palomeque has conducted research at Mount Sinai School of Medicine in molecular epidemiology and neurotoxins. She also coauthored several scientific papers which were peer-reviewed academic journals. “I am pleased to add someone with Caroline’s experience background to our Healthcare Platform. Healthcare is a core vertical at Maxim Group and Biotechnology is an important component,” said Anthony V. Vendetti, Executive Managing Director and Head of Equity Research at Maxim Group.\nMs. Palomeque holds an M.B.A. in Finance from Fordham University Graduate School of Business and a B.S. in Neuroscience from the University of Massachusetts Amherst.\nAbout Maxim Group LLC\nMaxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales & trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and NYSE Arca, Inc. To learn more about Maxim Group, visit www.maximgrp.com .\nFor further information please contact:\nJohn J. Garrity\nChief Marketing Officer\n212.895.3624\njgarrity@maximgrp.com\nSource:Maxim Group LLC", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/8a16239f-e2b8-4d87-af77-dd12d138c4cc", "https://www.globenewswire.com/Tracker?data=fHoWQDQ1c77nwiEwuIqzbKjrqaqAePVDzmlxT071YeBjpVcwb9Q24hD-yH-r2qa0biaEO2l9OYsc5lAmz8WbH2mZk5Y60UdiLXieSyFepzw=", "https://www.globenewswire.com/Tracker?data=HjEGvrcu0d-vFB-p9cVJ42Ba3ONdEN9tl4Jtn8qr7y7JfzbKYznAP52QDzJxW_9SSp9aqwdzeO2EbwXMt-_Obw=="], "published": "2018-04-30T16:00:00.000+03:00", "crawled": "2018-04-30T18:14:11.112+03:00", "highlightTitle": ""}